InBody USA (BIOSPACE)

InBody USA (BIOSPACE) is a leader in health technology, specializing in body composition analyzers that deliver accurate and non-invasive health metrics. Founded in 1996 by Dr. Kichul Cha, the company has expanded from a small biotech startup in South Korea to a multinational corporation operating in over 80 countries, including the United States. InBody is known for its innovative bioelectrical impedance analysis (BIA) technology, which provides tailored body composition data for individual users. The core products include body composition analyzers that utilize patented DSM-BIA technology and an 8-Point Tactile Electrode System. These devices offer insights into body fat percentage, muscle mass, basal metabolic rate, and body water distribution, with results available in under two minutes. InBody also provides clinically validated blood pressure monitors and stadiometers for medical settings, along with consumer products like body composition scales and fitness wearables. The company serves a diverse customer base, including medical institutions, research facilities, fitness centers, and individual consumers, emphasizing the importance of understanding health metrics for wellness goals.

• Employees 270
• Founded 2000
• Annual Revenue $138591000